Franco M. Muggia

25.9k citations
547 papers · 19.3k · 5 hit papers · h-index 65

Impact in

    • Ovarian cancer diagnosis and treatment
  • Oncology top 0.1%
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Treatments and Studies

Papers in

    • Cancer Treatment and Pharmacology 127
    • Lung Cancer Research Studies 45
    • Colorectal Cancer Treatments and Studies 40
    • Ovarian cancer diagnosis and treatment 106

Franco M. Muggia

533 papers receiving 18.2k citations

Franco M. Muggia's Hit Papers

Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study 2007 · 663 citations
6630+15+30Years since publication200400600

Peers

Franco M. Muggia
Comparison fields: 5 of 176
  • Reproductive Medicine 3.4k
  • Oncology 8.4k
  • Obstetrics and Gynecology 1.4k
  • Biomaterials 1.8k
  • Pathology and Forensic Medicine 2.2k
Replace Stan B. Kaye with:
Stan B. Kaye United Kingdom
Maurie Markman United States
Martin Gore United Kingdom
Ursula A. Matulonis United States
Eric K. Rowinsky United States
Pierfranco Conté Italy
Carolyn D. Runowicz United States
Susan Groshen United States
Stephen B. Howell United States
Herbert M. Pinedo Netherlands
Franco M. Muggia relative to Stan B. Kaye United Kingdom Stan B. Kaye's profile →
Citations per field
00.5×1.5×2.4×
Stan B. Kaye · 1×
Citations per year

Countries citing papers authored by Franco M. Muggia

Since Specialization
Citations

This map shows the geographic impact of Franco M. Muggia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franco M. Muggia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franco M. Muggia more than expected).

Fields of papers citing papers by Franco M. Muggia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franco M. Muggia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franco M. Muggia. The network helps show where Franco M. Muggia may publish in the future.

Co-authors

The 25 scholars most cited alongside Franco M. Muggia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Franco M. Muggia Line = papers co-authored together Franco M. Muggia links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 547 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Kaposis sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California.
Hit paper breakdown →
1981696
2
Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
Hit paper breakdown →
2007663
3
Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.
Hit paper breakdown →
1997513
4
Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2
Hit paper breakdown →
2000505
5
The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group.
Hit paper breakdown →
1989443
6 2000436
7 1995386
8 2003374
9 2011322
10 1977318
11 2007293
12 2010291
13 1998288
14
Toxic effects of cis-dichlorodiammineplatinum(II) in man.
1980285
15 1988281
16 1995280
17
Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies.
1972275
18 1987256
19
Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy.
2001253
20
Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.
2003225

About Franco M. Muggia

Franco M. Muggia is a scholar working on Oncology, Reproductive Medicine, Pulmonary and Respiratory Medicine, Molecular Biology and Surgery, having authored 547 papers that have together received 19.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (127 papers), Ovarian cancer diagnosis and treatment (106 papers), Intraperitoneal and Appendiceal Malignancies (57 papers), Lung Cancer Research Studies (45 papers), Lung Cancer Treatments and Mutations (41 papers), Colorectal Cancer Treatments and Studies (40 papers), Cancer therapeutics and mechanisms (39 papers) and Endometrial and Cervical Cancer Treatments (33 papers). The work is most often cited by research in Reproductive Medicine (3.4k citations), Oncology (8.4k citations), Obstetrics and Gynecology (1.4k citations), Biomaterials (1.8k citations) and Pathology and Forensic Medicine (2.2k citations). Franco M. Muggia has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Marcel Rozencweig, János Szebeni, Susan Jeffers, Alberto Gabizón, Heine H. Hansen, Daniel D. Von Hoff, Leonard Liebes, Susan Groshen, L Laubenstein and William P. McGuire. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Cancer Chemotherapy and Pharmacology, Cancer and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact